“CFDA Registration – Market Access Before Investment” delivered by Tim Lin, Technical Manager...

47
UL and the UL logo are trademarks of UL LLC © 2013 CFDA Registration Market Access Before Investment Tim Lin Technical Manager UL MDRS, AP Region Delivered June 26, 2013 by Webinar

description

Due to a large population, increasing middle class and government plans to build tens of thousands of hospitals, there is a lot of demand for high quality medical devices in China. For many foreign medical device manufacturers, the regulatory barriers are still significant obstacles. The medical device regulation in China is less harmonized and generally unique from other major markets. The primary challenges tend to be: actual testing, drafting standards, language barriers and license parking. These additional requirements create a delay in the registration process. Foreign manufacturers need to specifically understand the Chinese medical device regulation in advance, and then are able to determine appropriate strategies aimed at successful China market entry. This is the content for a live webinar, "CFDA Registration, Market Access before Investment...Solving the CFDA Challenge" delivered by UL's Tim Lin. Tim is the Senior Technical Consultant working in the Greater China Region. He majored in public health and medical device engineering, and worked as a reviewer in the Taiwan FDA for high and moderate-risk medical device and clinical trial protocol for over 5 years; and also drafted guidance for industry. He is now responsible for risk management file, usability engineering, software validation and CE MDD technical documentation.

Transcript of “CFDA Registration – Market Access Before Investment” delivered by Tim Lin, Technical Manager...

Page 1: “CFDA Registration – Market Access Before Investment” delivered by Tim Lin, Technical Manager for UL’s Medical Regulatory Advisory Services

UL and the UL logo are trademarks of UL LLC © 2013

CFDA Registration

– Market Access Before Investment

Tim Lin

Technical Manager

UL MDRS, AP Region

Delivered June 26, 2013 by Webinar

Page 2: “CFDA Registration – Market Access Before Investment” delivered by Tim Lin, Technical Manager for UL’s Medical Regulatory Advisory Services

Agenda

1. Overview of CFDA Registration

2. Key Registration Hurdles

3. Latest Regulatory Update

4. What UL can do for you

Page 3: “CFDA Registration – Market Access Before Investment” delivered by Tim Lin, Technical Manager for UL’s Medical Regulatory Advisory Services

Agenda

1. Overview of CFDA Registration

2. Key Registration Hurdles

3. Latest Regulatory Update

4. What UL can do for you

Page 4: “CFDA Registration – Market Access Before Investment” delivered by Tim Lin, Technical Manager for UL’s Medical Regulatory Advisory Services

Definition of Medical Device

It refers to those instruments, apparatus, appliances, materials and other objects, including the software attached to them, that are designed to be used either independently or in combination on human body. These devices are used for:

Diagnosis, prevention, monitoring, treatment or alleviation of disease;

Diagnosis, monitoring, treatment, alleviation of or compensation for an injury or handicap conditions

Investigation, replacement or modification for anatomy or a physiological process;

Control of conception.

Basically, the effect of these devices on human body is not achieved through means of pharmacology, immunology or metabolism; though they might be resorted to in order to bring about certain supplementary effect.

Source: http://eng.sfda.gov.cn/WS03/CL0767/61641.html

Page 5: “CFDA Registration – Market Access Before Investment” delivered by Tim Lin, Technical Manager for UL’s Medical Regulatory Advisory Services

Basic Regulatory Structure

1. 3 classifications based on risk

2. Similar to CE Mark and FDA, the classification

determines registration route.

3. Used for human. Animal use is not included.

Page 6: “CFDA Registration – Market Access Before Investment” delivered by Tim Lin, Technical Manager for UL’s Medical Regulatory Advisory Services

Device Classification

Class I: Under routine administration for their safety and efficacy,

Ex: Rehabilitation techniques, disinfecting devices and apparatus.

Class II: Controlled for their safety and efficacy,

Ex: Weak laser in-vitro treatment instruments.

Class III: Implanted into the human body, or used for life support or sustenance, and pose potential risk to human life, Ex: Implanted artificial internal organs and infant care devices.

Page 7: “CFDA Registration – Market Access Before Investment” delivered by Tim Lin, Technical Manager for UL’s Medical Regulatory Advisory Services

Criteria for Device Classification

7

Page 8: “CFDA Registration – Market Access Before Investment” delivered by Tim Lin, Technical Manager for UL’s Medical Regulatory Advisory Services

Non Active, Contacting Device

8

Skin/

Cavity & Tract

Trauma/

Tissue

Circulation;

Blood/Central

Skin/

Cavity & Tract

Trauma/

Tissue

Circulation;

Blood/Central

Skin/

Cavity & Tract

Trauma/

Tissue

Circulation;

Blood/Central

1Device for Transporation and

Storage of Pharmaceutical Liquid2 2 3 2 2 3 2 3 3

2Device for alternation of blood and

body fluids NA NA 3 NA NA 3 NA NA 3

3 Device for medical dressing 1 2 2 1 2 2 NA NA NA

4 Surgical instruments (inserted) 1 2 3 2 2 3 2 3 3

5 Reusable surgical instruments 1 1 2 NA NA NA NA NA NA

6 Disposible aspetic surgical device 1 2 3 2 3 3 2 3 3

7 Implantables NA NA NA NA NA NA 3 3 3

8Device for contraception and birth

control 2 2 3 2 3 3 3 3 3

9 Device for sterilization and cleaning 2 2 2 2 2 2 2 2 2

10 Other Non Active Devices 1 2 3 2 2 3 2 3 3

Temporary Use Short Term Use Long Term UseForm of Operation

Page 9: “CFDA Registration – Market Access Before Investment” delivered by Tim Lin, Technical Manager for UL’s Medical Regulatory Advisory Services

Active, Contacting Device

9

1Device of treatment with energy

source

2 Device for diagnostic monitoring

3 Device for body fluid transportation

4 Device with ionizing radiation

5 Other general active device

3

3

NA

Act

ive

De

vice

2

2

2

2

2

3

3

2

Form of OperationTemporary

Use

Short Term

Use

Long Term

Use

2

2

3

3

Page 10: “CFDA Registration – Market Access Before Investment” delivered by Tim Lin, Technical Manager for UL’s Medical Regulatory Advisory Services

Non-Contacting Device

10

1 Device for Patient Care

2 In Vitro Diagnostic Reagent

3Other Supplementary

Device

1 Device for Laboratory Use

2 Device for Sterilization

3Other Supplementary

Device

NA

1 2 NA

1 2 NA

Act

ive

De

vice

Form of Operation No Impact Indirect Impact Major Impact

1 2

2 3

1 2 NANo

n A

ctiv

e D

evi

ce Form of Operation No Impact Indirect Impact Major Impact

1 2 NA

1

Page 11: “CFDA Registration – Market Access Before Investment” delivered by Tim Lin, Technical Manager for UL’s Medical Regulatory Advisory Services
Page 12: “CFDA Registration – Market Access Before Investment” delivered by Tim Lin, Technical Manager for UL’s Medical Regulatory Advisory Services

Key Registration Component

12

Page 13: “CFDA Registration – Market Access Before Investment” delivered by Tim Lin, Technical Manager for UL’s Medical Regulatory Advisory Services

Required Document

1. Application form for registration of import medical device

2. Legal Qualification certification for medical device manufacturing enterprise.

3. A Copy of applicant’s business license and proxy for registration entrusted by the Manufacturing enterprise

4. Marketing approval from country of origin or device is accepted by medical device competent authority.

5. Applicable product standard and instructions

6. User’s manual / Operation Manual

Page 14: “CFDA Registration – Market Access Before Investment” delivered by Tim Lin, Technical Manager for UL’s Medical Regulatory Advisory Services

Required Document (cont’d)

7. Test report on product registration given by medical device inspection institutions (applicable to Class II and Class III medical device)

8. Clinical Trial Report, if required

9. Product Quality Guaranty by Manufacturer

10. Business License & Commitment Letter of local legal agent, the original entrust letter from manufacturer

11. Business License & Commitment Letter of local after sales agent and the original entrust letter from manufacturer

12. Self Declaration letter on material authenticity by manufacturers

Page 15: “CFDA Registration – Market Access Before Investment” delivered by Tim Lin, Technical Manager for UL’s Medical Regulatory Advisory Services

Application Process

Identify Application, Legal & After-Sales Agent(确认申请、代理人和售后代理人)

Technical Evaluation by CMDE(技术审评)

Determine Device Classification(确认类别)

Formulate Test Standard(起草产品标准)

File for Testing approval(取得检验报告)

Determine Clinical Evaluation Path(确定临床方案)

Conduct Clinical Study (if required)(临床试验)

Prepare Chinese Documents(申报资料准备)

Final Product Approval

Preview Original Registration Document(检

查原注册文件)

Page 16: “CFDA Registration – Market Access Before Investment” delivered by Tim Lin, Technical Manager for UL’s Medical Regulatory Advisory Services

Agenda

1. Overview of CFDA Registration

2. Key Registration Hurdles

3. Latest Regulatory Update

4. What UL can do for you

Page 17: “CFDA Registration – Market Access Before Investment” delivered by Tim Lin, Technical Manager for UL’s Medical Regulatory Advisory Services

Identify Agent of

Application, Legal and After-Sales

Registration Agent: To coordinate and control CFDA registration Qualification: business license

Legal Agent: Report any adverse events that occur inside or outside China to

CFDA Handle any recall incidence in China if arises Qualification: business license

After Sales Agent: Provide technical service and maintenance support, which must

be included in the business scope of the business license Qualification: business license

Agent Contact Person Must be a Chinese Resident.

Page 18: “CFDA Registration – Market Access Before Investment” delivered by Tim Lin, Technical Manager for UL’s Medical Regulatory Advisory Services

Product Standard : YZB

Manufacturer should create a YZB as one component of registration dossier.

YZB includes performance and safety items

If there is relevant GB/YY, manufacturer can adopt them (700 standards)

If no relevant GB/YY, or manufacturer is not willing to adapt Chinese standards, manufacturer should compile a product standard. (In latter case, parameters should be superior to superior to GB/YY)

Must be in Chinese

Page 19: “CFDA Registration – Market Access Before Investment” delivered by Tim Lin, Technical Manager for UL’s Medical Regulatory Advisory Services

Standards - Patient monitor

GB9706.1-2007 IEC60601-1:1988

A1:1991+A2:1995

Medical electrical equipment—Part 1:General

requirements for safety

YY 0505-2012

IEC 60601-1-2:20xx Medical electrical equipment—Part 1-2:General

requirements for safety—Collateral standard:

Electromagnetic compatibility—Requirements and

tests

19

GB/T16886.1-

2011

ISO 10993-1:2009 Biological evaluation of medical devices—Part

1:Evaluation and testing within a risk management

process

GB/T 191-2008

ISO 780:1997 Packaging—Pictorial marking for handling of goods

GB/T14710-

2009

- Environmental requirement and test methods for

medical electrical equipment

局令第10号 - Administrative Regulation of Medical Device

Specification, Label and Packaging Identification

Page 20: “CFDA Registration – Market Access Before Investment” delivered by Tim Lin, Technical Manager for UL’s Medical Regulatory Advisory Services

Standards - Patient monitor

GB9706.25-2005 IEC60601-2-27:1994 《医用电气设备 第2-27部分:心电监护设备安全专用要求》

Medical electrical equipment—Part 2:Particular requirements for

the safety of electrocardiographic monitoring equipment

YY0667-2008

IEC60601-2-30:1999 Medical electrical equipment—Part 2-30:Particular requirements

for the safety, including essential performance, of automatic

cycling non-invasive blood pressure monitoring equipment

YY0668-2008

IEC60601-2-49:2001 《医用电气设备 第2部分:多参数患者监护设备安全专用要求》

Medical electrical equipment—Part 2-49:Particular requirements

for the safety of multifunction patient monitoring equipment

YY 0709-2008

IEC 60601-1-8:2003

Medical electrical equipment—Part 1-8:General requirements for

safety—Collateral standard: General requirements, tests and

guidance for alarm systems in medical electrical equipment and

medical electrical systems

YY 1079-2008

- 《心电监护仪》

Electrocardiographic monitors

YY 0670-2008

无创自动血压计

Non-invasive automated sphygmomanometer

20

YY/T 0196-2005

- Disposable ECG electrodes

Page 21: “CFDA Registration – Market Access Before Investment” delivered by Tim Lin, Technical Manager for UL’s Medical Regulatory Advisory Services

Testing Approval (Actual testing)

Mandatory to test the product at a CFDA accredited center

Obtain test report before regulatory submission is required.

Type Test Report should be within past 12 months

Usually testing report restrict the submitting time

Page 22: “CFDA Registration – Market Access Before Investment” delivered by Tim Lin, Technical Manager for UL’s Medical Regulatory Advisory Services

Clinical Evaluation

Clinical Evaluation documents for registration in the country of origin;

If there is no clinical trial report from the country of origin, manufacturer should provide the evidence (rule, regulation, etc), and also provide clinical information after selling

If the manufacturer of a Class III implant product is the 1st time entry of China market, it is required to conduct a clinical study in China.

New Announcement: Clinical evaluation report of some class II items can be instead of comparison result with similar product

Must be in Chinese

Page 23: “CFDA Registration – Market Access Before Investment” delivered by Tim Lin, Technical Manager for UL’s Medical Regulatory Advisory Services

User’s Manual

Based on the Manual of original

GB/T 9969-2008 General principles for instructions

for use

10th Administrative Order: Administrative Regulation

of Medical Device Specification, Label and

Packaging Identification

Must be in Chinese

Page 24: “CFDA Registration – Market Access Before Investment” delivered by Tim Lin, Technical Manager for UL’s Medical Regulatory Advisory Services

Software Requirements

April 28th 2012

Need to provide additional Software Document.

Page 25: “CFDA Registration – Market Access Before Investment” delivered by Tim Lin, Technical Manager for UL’s Medical Regulatory Advisory Services

Agenda

1. Overview of CFDA Registration

2. Key Registration Hurdles

3. Latest Regulatory Update

4. What UL can do for you

Page 26: “CFDA Registration – Market Access Before Investment” delivered by Tim Lin, Technical Manager for UL’s Medical Regulatory Advisory Services

CCC mark

2013 Announcement No.52

In the past, 8 medical device need to additionally tested

for CCC (China Compulsory Certification) mark.

Medical X-ray diagnostic equipment,

Hemodialysis equipment,

Hollow fiber dialyzers,

Extracorporeal blood circuit for blood purification equipment,

Artificial heart-lung machines,

ECGs,

Implantable cardiac pacemakers

Rubber condoms.

No need any more since May 2 2013.

Page 27: “CFDA Registration – Market Access Before Investment” delivered by Tim Lin, Technical Manager for UL’s Medical Regulatory Advisory Services

Administration Level Change - CFDA

March 22nd 2013

1. SFDA has elevated to Ministerial department (From

vice-ministerial), its name also changed to “CFDA”.

2. Independent medical device registration

department

3. The previous regulation/policy is still valid.

http://www.sfda.gov.cn/WS01/CL0051/79254.html

Page 28: “CFDA Registration – Market Access Before Investment” delivered by Tim Lin, Technical Manager for UL’s Medical Regulatory Advisory Services

Software Requirements

April 28th 2012

Need to provide additional Software Document.

Page 29: “CFDA Registration – Market Access Before Investment” delivered by Tim Lin, Technical Manager for UL’s Medical Regulatory Advisory Services

Software Requirements

April 28th 2012

Software type:

Independent software: Software as medical device or

accessory, such as processing software, data software.

Software component: Software as component of medical device, part or accessory, such as embedded software, control software.

Specialized software: such as individual customer-made software.

Page 30: “CFDA Registration – Market Access Before Investment” delivered by Tim Lin, Technical Manager for UL’s Medical Regulatory Advisory Services

Software Requirements

April 28th 2012 (cont’d)

Risk Classification of Software Class A: No injury or damage to health is possible

Class B: Non-SERIOUS INJURY is possible

Class C: Death or SERIOUS INJURY is possible

Quantity and level of detail depends on software risk classification.

Page 31: “CFDA Registration – Market Access Before Investment” delivered by Tim Lin, Technical Manager for UL’s Medical Regulatory Advisory Services

Software Requirements - Contents

April 28th 2012 (cont’d)

1. Basic Information (基本信息)

1.1 Product Identification (产品标识)

1.2 Safety Class (安全性类别)

1.3 Architecture Function (结构功能)

1.4 Hardware Relationship(硬件关系)

1.5 Operation Environment (运行环境)

1.6 Indications (适用范围)

1.7 Contraindications (禁忌症)

1.8 Listing History (上市历史)

Page 32: “CFDA Registration – Market Access Before Investment” delivered by Tim Lin, Technical Manager for UL’s Medical Regulatory Advisory Services

Software Requirements - Contents

April 28th 2012 (cont’d)

2. Development Process (实现过程)

2.1 Development Review (开发综述)

2.2 Risk Management (风险管理)

2.3 Requirement Specification (需求规格)

2.4 Lifecycle (生存周期)

2.5 Verification and Validation (验证与确认)

2.6 Defect Management (缺陷管理)

2.7 Revision History (修订历史)

2.8 Clinical Evaluation (临床评价)

3. Core Algorithm (核心算法)

Page 33: “CFDA Registration – Market Access Before Investment” delivered by Tim Lin, Technical Manager for UL’s Medical Regulatory Advisory Services

Some Class II Devices are Exempted From

Clinical Evaluation Data (国食药监械[2011]475号)

A list of these devices exempted from clinical

evaluation data

Document of comparison results shall be

provided

Page 34: “CFDA Registration – Market Access Before Investment” delivered by Tim Lin, Technical Manager for UL’s Medical Regulatory Advisory Services

EMC Requirements

国食药监械[2012]151号

YY0505-2012 医用电气设备 第1-2部分:安全通用要求并列标准: 电电磁兼容要求和试验

(Harmonized to IEC60601-1-2 : 2004: Medical electrical equipment—Part 1-2:General requirements for safety—Collateral standard: Electromagnetic compatibility—Requirements and tests)

The date of taking effect (submit EMC report)

Class III Device : 1st Jan 2014

Class II Device : 1st Jan 2015

Page 35: “CFDA Registration – Market Access Before Investment” delivered by Tim Lin, Technical Manager for UL’s Medical Regulatory Advisory Services

Label & package marks

国食药监械[2012]280号

It must include Chinese label/package marks, other

language is allowed.

The procedure of producing Chinese Label/package

marks must be included in production of device,

under manufacture quality system control.

It is no more allowed to paste the labeling by agent

after device is shipped to China.

Page 36: “CFDA Registration – Market Access Before Investment” delivered by Tim Lin, Technical Manager for UL’s Medical Regulatory Advisory Services

Factors influence approval time

Quality of the documentations

Writing YZB and Software Documents

Time frame of actual testing

Re-work

Language Barrier (All documents must be in Chinese)

Page 37: “CFDA Registration – Market Access Before Investment” delivered by Tim Lin, Technical Manager for UL’s Medical Regulatory Advisory Services
Page 38: “CFDA Registration – Market Access Before Investment” delivered by Tim Lin, Technical Manager for UL’s Medical Regulatory Advisory Services

Agenda

1. Overview of CFDA Registration

2. Key Registration Hurdles

3. Latest Regulatory Update

4. What UL provides

Page 39: “CFDA Registration – Market Access Before Investment” delivered by Tim Lin, Technical Manager for UL’s Medical Regulatory Advisory Services

Now you are facing,

Search legal / after-sale agent first, then

initiate product registration.

Delay Registration

Page 40: “CFDA Registration – Market Access Before Investment” delivered by Tim Lin, Technical Manager for UL’s Medical Regulatory Advisory Services

UL provides,

Legal / After-sales agents

To let you start product registration ASAP

To let you search your partner when registration is

in-process

You can transfer license to your legal / after sale

partner after getting product license,

Delay Registration

Page 41: “CFDA Registration – Market Access Before Investment” delivered by Tim Lin, Technical Manager for UL’s Medical Regulatory Advisory Services

Testing Draft

Product Standard Assembly Dossier CFDA Assessment

Registration

Search for distributor

6 ~ 8 months 4 ~ 6 months Start selling right after finding distributor

Introducing Product Agent for CFDA Registration

Introducing After-Sale Agent for CFDA Registration

More benefit to customer:

• UL has partners for business matching ability to help customer for finding the

right business partner.

• UL can help customer understand the market characters.

Page 42: “CFDA Registration – Market Access Before Investment” delivered by Tim Lin, Technical Manager for UL’s Medical Regulatory Advisory Services

Now you are facing,

Do not know how to write YZB

Delay Registration

Page 43: “CFDA Registration – Market Access Before Investment” delivered by Tim Lin, Technical Manager for UL’s Medical Regulatory Advisory Services

UL provides,

Professional Local Expert

To write YZB based on your product

Established product category documentation

Delay Registration

Page 44: “CFDA Registration – Market Access Before Investment” delivered by Tim Lin, Technical Manager for UL’s Medical Regulatory Advisory Services

Now you are facing,

Do not know how to write

Software Documents

Delay Registration

Page 45: “CFDA Registration – Market Access Before Investment” delivered by Tim Lin, Technical Manager for UL’s Medical Regulatory Advisory Services

UL provides,

Professional Local Expert

To write software requirement document based

on your software documents

Delay Registration

Page 46: “CFDA Registration – Market Access Before Investment” delivered by Tim Lin, Technical Manager for UL’s Medical Regulatory Advisory Services

Your Benefit

46

• Start the CFDA Regulation work at anytime before any investment in China.

• Early entry ticket;

− Allowing manufacturer to research the market with less pressure for better decision.

− Allowing manufacturer has better bargain power for selecting good business partner.

• Minimize the cultural impact as UL has a good understanding of the US regulation, CE MDD Regulation and China regulation which is able to lead customer get into the right direction of registration work in China.

• Trusted Partner in China for searching business partner.

Page 47: “CFDA Registration – Market Access Before Investment” delivered by Tim Lin, Technical Manager for UL’s Medical Regulatory Advisory Services

Thank you

Contact Information:

[email protected]